奔月生物 (873255.OC)

+ 收藏

现金流量表(奔月生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、经营活动产生的现金流量
 销售商品、提供劳务收到的现金(元) 44,467,784.9972,095,646.9732,842,012.5483,551,631.9334,159,979.94
 收到的税费返还(元) -172,454.33172,454.33267,185.84-
 收到其他与经营活动有关的现金(元) 207,706.42526,501.05357,375.80706,825.51385,297.20
 经营活动现金流入小计(元) 44,675,491.4172,794,602.3533,371,842.6784,525,643.2834,545,277.14
 购买商品、接受劳务支付的现金(元) 42,065,045.8254,984,759.8025,893,920.5444,797,067.9522,815,202.42
 支付给职工以及为职工支付的现金(元) 5,358,918.358,507,548.194,333,090.1010,100,048.805,616,403.21
 支付的各项税费(元) 411,335.643,345,032.061,375,973.542,189,184.79136,001.51
 支付其他与经营活动有关的现金(元) 9,378,516.902,932,573.141,336,725.447,495,169.33379,644.96
 经营活动现金流出小计(元) 57,213,816.7169,769,913.1932,939,709.6264,581,470.8728,947,252.10
 经营活动产生的现金流量净额(元) -12,538,325.303,024,689.16432,133.0519,944,172.415,598,025.04
二、投资活动产生的现金流量
 处置固定资产、无形资产和其他长期资产收回的现金净额(元) 1,500.00--30,973.45-
 收到其他与投资活动有关的现金(元) ---226,238.15-
 投资活动现金流入小计(元) 1,500.00--257,211.60-
 购建固定资产、无形资产和其他长期资产支付的现金(元) 2,693,097.705,613,748.672,136,665.476,188,656.943,104,104.83
 投资支付的现金(元) 2,700,000.00----
 支付其他与投资活动有关的现金(元) 2,100.00----
 投资活动现金流出小计(元) 5,395,197.705,613,748.672,136,665.476,188,656.943,104,104.83
 投资活动产生的现金流量净额(元) -5,393,697.70-5,613,748.67-2,136,665.47-5,931,445.34-3,104,104.83
三、筹资活动产生的现金流量
 吸收投资收到的现金(元) 2,940,000.001,000,000.00---
  其中:子公司吸收少数股东投资收到的现金(元) 2,940,000.001,000,000.00---
 取得借款收到的现金(元) 14,000,000.0034,900,000.0017,000,000.0028,900,000.0011,000,000.00
 筹资活动现金流入小计(元) 16,940,000.0035,900,000.0017,000,000.0028,900,000.0011,000,000.00
 偿还债务支付的现金(元) 17,000,000.0028,900,000.0015,900,000.0024,800,000.009,900,000.00
 分配股利、利润或偿付利息支付的现金(元) -3,271,647.892,490,601.534,138,332.453,542,976.44
 支付其他与筹资活动有关的现金(元) -65,292.00---
 筹资活动现金流出小计(元) 17,000,000.0032,236,939.8918,390,601.5328,938,332.4513,442,976.44
 筹资活动产生的现金流量净额(元) -60,000.003,663,060.11-1,390,601.53-38,332.45-2,442,976.44
四、汇率变动对现金及现金等价物的影响(元) -39,832.4914,029.9440,595.9331,667.43
五、现金及现金等价物净增加额(元) -17,992,023.001,113,833.09-3,081,104.0114,014,990.5582,611.20
 加:期初现金及现金等价物余额(元) 18,226,410.6517,112,577.5617,112,577.563,097,587.013,097,587.01
 期末现金及现金等价物余额(元) 234,387.6518,226,410.6514,031,473.5517,112,577.563,180,198.21
补充资料:
 净利润(元) 3,883,883.79124,538.48-259,031.784,009,466.842,759,888.32
 资产减值准备(元) 106,477.91-497,280.77-534,771.30-61,528.38-175,199.30
 固定资产和投资性房地产折旧(元) 1,771,081.083,431,020.621,799,408.743,130,865.141,589,574.08
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧(元) 1,771,081.083,431,020.621,799,408.743,130,865.141,589,574.08
 无形资产摊销(元) 45,004.9489,009.8844,504.9489,176.5544,504.94
 长期待摊费用摊销(元) 308,212.39----
 处置固定资产、无形资产和其他长期资产的损失(元) 66,431.46---22,386.89-
 固定资产报废损失(元) -1,004.15----
 财务费用(元) 660,578.681,233,834.87534,875.091,101,879.96546,816.33
 递延所得税(元) 23,895.88-428,817.96-148,199.51-163,893.59-77,609.68
  其中:递延所得税资产减少(元) 23,895.88-462,057.68-148,199.51-163,893.59-77,609.68
 递延所得税负债增加(元) -33,239.72---
 存货的减少(元) -12,897,758.71-1,310,719.53-3,560,614.835,056,025.16-3,905,400.13
 经营性应收项目的减少(元) -18,944,427.879,768,462.369,064,175.776,244,449.757,344,636.43
 经营性应付项目的增加(元) -1,409,665.81-10,554,891.32-7,391,876.75-898,406.87-3,206,576.27
 其他(元) 13,848,965.111,169,532.53883,662.681,458,524.74677,390.32
 现金的期末余额(元) 234,387.6518,226,410.6514,031,473.5517,112,577.563,180,198.21
 减:现金的期初余额(元) 18,226,410.6517,112,577.5617,112,577.563,097,587.013,097,587.01
 现金及现金等价物的净增加额(元) -17,992,023.001,113,833.09-3,081,104.0114,014,990.5582,611.20
公告日期 2024-08-052024-04-162023-08-292023-04-182022-08-16
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院